| pubmed-article:20218123 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:20218123 | lifeskim:mentions | umls-concept:C0041296 | lld:lifeskim |
| pubmed-article:20218123 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:20218123 | lifeskim:mentions | umls-concept:C1707455 | lld:lifeskim |
| pubmed-article:20218123 | lifeskim:mentions | umls-concept:C0040808 | lld:lifeskim |
| pubmed-article:20218123 | lifeskim:mentions | umls-concept:C1280519 | lld:lifeskim |
| pubmed-article:20218123 | pubmed:issue | 6 | lld:pubmed |
| pubmed-article:20218123 | pubmed:dateCreated | 2010-3-11 | lld:pubmed |
| pubmed-article:20218123 | pubmed:abstractText | We compared the effectiveness of 2 treatment regimens for isoniazid-resistant tuberculosis (TB) in 42 patients attending a TB referral centre in the Islamic Republic of Iran. The patients were divided into 2 treatment groups: 26 received the 6-month standard HRZE treatment and 16 received a modified treatment of RZE for 6 months. There were no significant differences in age or sex of the groups. With the standard method of treatment, 21 (80.8%) patients were cured, 4 (15.4%) resulted in treatment failure, and 1 (3.8%) died. In the modified treatment group, 16 (100%) patients were cured, These differences were not statistically significantly different (P = 0.194). | lld:pubmed |
| pubmed-article:20218123 | pubmed:language | eng | lld:pubmed |
| pubmed-article:20218123 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20218123 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:20218123 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20218123 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20218123 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20218123 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20218123 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20218123 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:20218123 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:20218123 | pubmed:issn | 1020-3397 | lld:pubmed |
| pubmed-article:20218123 | pubmed:author | pubmed-author:MasjediM RMR | lld:pubmed |
| pubmed-article:20218123 | pubmed:author | pubmed-author:KazempourMM | lld:pubmed |
| pubmed-article:20218123 | pubmed:author | pubmed-author:MansouriDD | lld:pubmed |
| pubmed-article:20218123 | pubmed:author | pubmed-author:TabarsiPP | lld:pubmed |
| pubmed-article:20218123 | pubmed:author | pubmed-author:BaghaeiPP | lld:pubmed |
| pubmed-article:20218123 | pubmed:author | pubmed-author:MirsaeidiMM | lld:pubmed |
| pubmed-article:20218123 | pubmed:author | pubmed-author:HemmatiNN | lld:pubmed |
| pubmed-article:20218123 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:20218123 | pubmed:volume | 15 | lld:pubmed |
| pubmed-article:20218123 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:20218123 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:20218123 | pubmed:pagination | 1346-50 | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:meshHeading | pubmed-meshheading:20218123... | lld:pubmed |
| pubmed-article:20218123 | pubmed:articleTitle | Comparison of the effectiveness of 2 treatment regimens in patients with isoniazid-resistant tuberculosis. | lld:pubmed |
| pubmed-article:20218123 | pubmed:affiliation | Mycobacteriology Research Centre, National Research Institute of Tuberculosis and Lung Disease, Shaheed Beheshti University of Medical Sciences, Tehran, Islamic Republic of Iran. tabarsi@nritld.ac.ir | lld:pubmed |
| pubmed-article:20218123 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:20218123 | pubmed:publicationType | Comparative Study | lld:pubmed |
